Shalby Stock Screener | Share Price & Fundamental Analysis
SHALBY
Hospitals
Screen Shalby share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹192.61
▼
-2.91 (-1.49%)
Share Price BSE
₹192.45
▼
-3.05 (-1.56%)
Market Cap
₹2,197.35 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.18
EPS (TTM)
₹0.18
Dividend Yield
-
Debt to Equity
0.43
52W High
₹267.00
52W Low
₹180.06
Operating Margin
15.00%
Profit Margin
2.41%
Revenue (TTM)
₹290.00
EBITDA
₹46.00
Net Income
₹7.00
Total Assets
₹1,704.00
Total Equity
₹995.00
Shalby Share Price History - Stock Screener Chart
Screen SHALBY historical share price movements with interactive charts. Analyze price trends and patterns.
Shalby Company Profile - Fundamental Screener
Screen Shalby company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHALBY shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE597J01018
Shalby Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SHALBY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 1,704 | 1,608 | 1,281 | 1,194 | 997 | 967 | 939 | 961 | 679 |
| Current Assets | 658 | 552 | 517 | 449 | 271 | 234 | 197 | 212 | 89 |
| Fixed Assets | 955 | 966 | 685 | 675 | 660 | 673 | 692 | 650 | 323 |
| Liabilities | |||||||||
| Total Liabilities | 1,704 | 1,608 | 1,281 | 1,194 | 997 | 967 | 939 | 961 | 679 |
| Current Liabilities | 253 | 277 | 159 | 145 | 80 | 84 | 71 | 95 | 298 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 995 | 1,008 | 928 | 876 | 835 | 799 | 780 | 752 | 251 |
| Share Capital | 108 | 107 | 107 | 108 | 108 | 108 | 108 | 108 | 87 |
| Reserves & Surplus | 885 | 893 | 820 | 768 | 727 | 691 | 672 | 643 | 164 |
Screen SHALBY income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290 | 303 | 270 | 249 | 289 | 275 | 281 | 208 | 240 | 243 | 221 | 167 | 206 | 207 | 207 |
| Expenses | 244 | 255 | 244 | 205 | 234 | 235 | 242 | 173 | 192 | 185 | 174 | 139 | 162 | 165 | 169 |
| EBITDA | 46 | 49 | 26 | 44 | 55 | 40 | 39 | 35 | 48 | 58 | 47 | 28 | 44 | 42 | 38 |
| Operating Profit % | 15.00% | 14.00% | 8.00% | 16.00% | 16.00% | 12.00% | 12.00% | 13.00% | 18.00% | 22.00% | 20.00% | 15.00% | 20.00% | 18.00% | 17.00% |
| Depreciation | 17 | 17 | 16 | 16 | 16 | 17 | 16 | 13 | 12 | 12 | 12 | 11 | 12 | 12 | 12 |
| Interest | 10 | 9 | 11 | 7 | 8 | 9 | 11 | 3 | 3 | 3 | 4 | 2 | 2 | 2 | 3 |
| Profit Before Tax | 19 | 23 | -1 | 22 | 30 | 14 | 12 | 19 | 33 | 43 | 31 | 15 | 31 | 29 | 24 |
| Tax | 12 | 15 | 11 | 6 | 16 | 11 | 15 | 5 | 12 | 15 | 12 | 5 | 11 | 10 | 8 |
| Net Profit | 7 | 8 | -12 | 16 | 15 | 2 | -3 | 14 | 21 | 28 | 19 | 10 | 20 | 18 | 15 |
| EPS | 0.68 | 0.71 | -1.13 | 1.49 | 1.37 | 0.22 | -0.28 | 1.29 | 1.94 | 2.57 | 1.78 | 0.94 | 1.87 | 1.71 | 1.42 |
Shalby Cash Flow Screener - Liquidity Fundamentals
Screen SHALBY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -4 | 20 | 68 | 19 | 79 | 55 | 43 | 14 | 61 | 5 |
| Investing Activities | -36 | 146 | -61 | -60 | -51 | -31 | 1 | -236 | -153 | -98 |
| Financing Activities | 48 | -151 | -50 | 91 | -30 | -22 | -51 | 222 | 96 | 75 |
| Net Cash Flow | 8 | 15 | -43 | 49 | -2 | 3 | -6 | 0 | 3 | -19 |
Screen SHALBY shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.27% | 74.27% | 74.33% | 74.24% | 74.25% | 74.25% | 74.27% | 74.12% |
| FII Holding | 4.54% | 5.20% | 4.64% | 4.88% | 5.35% | 5.37% | 4.65% | 0.00% |
| DII Holding | 0.18% | 0.20% | 0.20% | 0.00% | 0.06% | 0.09% | 0.14% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.67% | 11.20% | 11.74% | 10.40% | 9.97% | 10.09% | 10.78% | 11.13% |
| Other Holding | 10.34% | 9.13% | 9.11% | 10.49% | 10.37% | 10.20% | 10.16% | 14.75% |
| Shareholder Count | 52,895 | 53,437 | 53,784 | 49,858 | 49,315 | 51,479 | 52,328 | 52,181 |
Shalby Dividend Screener - Share Yield Analysis
Screen SHALBY dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹1.20 | 0.61% |
| 2023-March | ₹1.20 | 0.50% |
| 2022-March | ₹1.00 | 0.77% |
| 2021-March | ₹1.00 | 0.85% |
| 2020-March | ₹0.50 | 0.50% |
| 2019-March | ₹0.50 | 1.08% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Shalby Index Membership - Market Screener Classification
Screen SHALBY by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Shalby Market Events Screener - Corporate Actions
Screen SHALBY market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 22.90% | ||
| Dividend | ₹ 1.00 /share | 34.47% | ||
| Dividend | ₹ 1.00 /share | 37.51% | ||
| Dividend | ₹ 1.20 /share | -2.00% | ||
| Annual General Meeting | NA | 1.82% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -5.45% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -0.85% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.21% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | 5.58% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 7.76% |
| 2023-08-08 | 2023-08-09 | Dividend | ₹ 1.20 /share | 33.67% |
Shalby Competitors Screener - Peer Comparison
Screen SHALBY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Max Healthcare Institute | 103,152 | 75.17 | 7,184 | 28.65% | 1,076 | 38.86 |
| Apollo Hospitals | 102,159 | 59.14 | 21,994 | 14.76% | 1,505 | 46.86 |
| Fortis Healthcare | 69,569 | 65.35 | 7,850 | 13.25% | 809 | 49.90 |
| Narayana Hrudayalaya | 39,364 | 46.76 | 5,575 | 12.29% | 790 | 57.19 |
| Global Health | 32,653 | 57.06 | 3,771 | 12.59% | 481 | 51.45 |
| Aster DM Healthcare | 31,631 | 86.09 | 4,287 | 15.12% | 337 | 40.34 |
| Krishna Institute of Medical Sciences | 25,323 | 69.30 | 3,067 | 21.98% | 415 | 33.50 |
| Dr. Agarwal's Health Care | 15,831 | 109.02 | 1,757 | 27.64% | 110 | 47.42 |
| Kovai Medical Center Hospital | 13,979 | 27.37 | 600 | 11.69% | 58 | 34.31 |
| Rainbow Childrens Medicare | 13,467 | 52.38 | 1,567 | 17.46% | 244 | 41.00 |
Shalby Company Announcements - News Screener
Screen SHALBY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-02 | Closure of Trading Window | View |
| 2025-12-18 | Monthly Report On Re-Lodgement For Transfer Requests Of Physical Shares For The Month November 2025 | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Grant Of 19000 Employee Stock Options | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Disclosure Under Reg. 30(5) For Determining Materiality Of An Event Or Information And To Make Disclosure To Stock Exchanges | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-12 | Exercise Of 2000 Esops By Eligible Employee | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-07 | Issuance Of Corporate Guarantee For Fund And Non-Fund Based Credit Facilities Granted To PK Healthcare Private Limited (Subsidiary Company) | View |
| 2025-11-07 | Monthly Report On Re-Lodgement For Transfer Requests Of Physical Shares For The Month October 2025 | View |
| 2025-11-05 | Board Meeting Intimation for Unaudited Results Of Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-25 | Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window | View |
| 2025-10-24 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | View |